BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12472285)

  • 1. Comparison of thyroid transcription factor-1 and hepatocyte antigen immunohistochemical analysis in the differential diagnosis of hepatocellular carcinoma, metastatic adenocarcinoma, renal cell carcinoma, and adrenal cortical carcinoma.
    Wieczorek TJ; Pinkus JL; Glickman JN; Pinkus GS
    Am J Clin Pathol; 2002 Dec; 118(6):911-21. PubMed ID: 12472285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY; Bourne PA; diSant'Agnese PA; Huang J
    Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic immunoreactivity for thyroid transcription factor-1 in hepatocellular carcinoma: a comparative immunohistochemical analysis of four commercial antibodies using a tissue array technique.
    Pan CC; Chen PC; Tsay SH; Chiang H
    Am J Clin Pathol; 2004 Mar; 121(3):343-9. PubMed ID: 15023038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
    Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
    Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors.
    Renshaw AA; Granter SR
    Mod Pathol; 1998 Dec; 11(12):1160-4. PubMed ID: 9872645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma.
    Karabork A; Kaygusuz G; Ekinci C
    Pathol Res Pract; 2010 Aug; 206(8):572-7. PubMed ID: 20400233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases.
    Zamecnik J; Kodet R
    Virchows Arch; 2002 Apr; 440(4):353-61. PubMed ID: 11956814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers.
    Wu M; Szporn AH; Zhang D; Wasserman P; Gan L; Miller L; Burstein DE
    Diagn Cytopathol; 2005 Oct; 33(4):223-7. PubMed ID: 16138374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.
    Wick MR; Cherwitz DL; McGlennen RC; Dehner LP
    Am J Pathol; 1986 Feb; 122(2):343-52. PubMed ID: 2418689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of antihepatocyte clone OCH1E5 (Hep Par 1) in histological evaluation of liver tumors.
    Amarapurkar AD; Rege JD; Joshi AS; Vaiphei K; Amarapurkar DN
    Indian J Pathol Microbiol; 2006 Jul; 49(3):341-4. PubMed ID: 17001880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MOC-31 aids in the differentiation of metastatic adenocarcinoma from hepatocellular carcinoma.
    Niemann TH; Hughes JH; De Young BR
    Cancer; 1999 Oct; 87(5):295-8. PubMed ID: 10536355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostaining for thyroid transcription factor-1 on fine-needle aspiration specimens of lung tumors: a comparison of direct smears and cell block preparations.
    Liu J; Farhood A
    Cancer; 2004 Apr; 102(2):109-14. PubMed ID: 15098255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte paraffin 1 expression in human normal and neoplastic tissues: tissue microarray analysis on 3,940 tissue samples.
    Lugli A; Tornillo L; Mirlacher M; Bundi M; Sauter G; Terracciano LM
    Am J Clin Pathol; 2004 Nov; 122(5):721-7. PubMed ID: 15491968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver.
    Gokden M; Shinde A
    Diagn Cytopathol; 2005 Sep; 33(3):166-72. PubMed ID: 16078249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of immunohistochemical expression of TTF-1, CK7 and CK20 in the diagnosis of primary and secondary lung carcinomas.
    Al-Zahrani IH
    Saudi Med J; 2008 Jul; 29(7):957-61. PubMed ID: 18626520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin gene expression in liver tumors: diagnostic interest in fine needle aspiration biopsies.
    Papotti M; Pacchioni D; Negro F; Bonino F; Bussolati G
    Mod Pathol; 1994 Apr; 7(3):271-5. PubMed ID: 8058698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic differentiation of hepatocellular carcinoma from adenocarcinoma by a simple panel: evaluation of the pitfalls.
    Geramizadeh B; Boub R; Rahsaz M
    Indian J Pathol Microbiol; 2007 Jul; 50(3):507-10. PubMed ID: 17883119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
    Morrison C; Marsh W; Frankel WL
    Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.